Location History:
- Lille, FR (2012)
- Phalempin, FR (2015 - 2016)
Company Filing History:
Years Active: 2012-2016
Title: Juergen Siepmann: Innovator in Pharmaceutical Composition
Introduction
Juergen Siepmann is a notable inventor based in Phalempin, France. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of controlled-release formulations. With a total of 3 patents, his work has advanced the understanding and application of modified starch derivatives and polymeric mixtures in drug delivery systems.
Latest Patents
One of Siepmann's latest patents is focused on a modified starch derivative-based matrix for colon targeting. This invention describes a controlled-release oral pharmaceutical composition that includes a lipophilic matrix made of lipophilic and/or amphiphilic compounds, along with a hydrophilic matrix containing an indigestible polysaccharide. The active ingredient is dispersed within these matrices, enhancing its delivery to the colon.
Another significant patent involves water-insoluble polymer coatings for colon targeting. This controlled-release pharmaceutical dosage form features an active ingredient coated with a polymeric mixture that includes at least one water-insoluble polymer and an indigestible water-soluble oligosaccharide. The patent also outlines the methods for making these innovative formulations.
Career Highlights
Throughout his career, Juergen Siepmann has worked with prominent companies such as Roquette Frères and FMC Corporation. His experience in these organizations has allowed him to refine his expertise in pharmaceutical sciences and contribute to various innovative projects.
Collaborations
Siepmann has collaborated with notable colleagues, including Olaf Haeusler and Daniel Wils. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical technology.
Conclusion
Juergen Siepmann's contributions to the field of pharmaceutical compositions demonstrate his commitment to innovation and excellence. His patents reflect a deep understanding of drug delivery systems, paving the way for future advancements in the industry.